Kuros Biosciences AG (SWX: KURN)
Switzerland
· Delayed Price · Currency is CHF 16.98
-0.08 (-0.47%)
Sep 4, 2024, 5:30 PM CET
Kuros Biosciences AG Cash Flow Statement
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -80.47 | -8.63 | 101.77 | 15.33 | -64.63 | 13.06 | Upgrade
|
| Depreciation & Amortization | 13.11 | 15.5 | 16.23 | 14.16 | 15.33 | 17.13 | Upgrade
|
| Other Amortization | 30.08 | 30.08 | 25.76 | 25.78 | 10.8 | 13.41 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | 4.16 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 65.42 | 65.42 | - | 0.07 | 74.12 | 12.65 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | 0.04 | 0.05 | 0.07 | Upgrade
|
| Loss (Gain) on Equity Investments | 0.17 | 0.2 | 0.12 | 1.82 | 4.16 | 4.25 | Upgrade
|
| Stock-Based Compensation | 5.74 | 4.48 | 4.3 | 3.32 | 4.76 | 5.26 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | - | - | -0.02 | -0.36 | Upgrade
|
| Other Operating Activities | -14.55 | -7.87 | 24.8 | 5.3 | -8.43 | -4.36 | Upgrade
|
| Change in Accounts Receivable | 72.52 | -17.89 | -18.17 | -1.01 | -2.88 | 6.15 | Upgrade
|
| Change in Inventory | 29.67 | 13.89 | -86.53 | 1.55 | 18.02 | 6.4 | Upgrade
|
| Change in Accounts Payable | -42.57 | -41.89 | 46.51 | 26.68 | -10.68 | 2.3 | Upgrade
|
| Change in Other Net Operating Assets | 5.88 | 5.87 | 2.53 | 0.48 | -1.09 | 1.34 | Upgrade
|
| Operating Cash Flow | 85 | 59.17 | 117.32 | 97.69 | 39.52 | 77.29 | Upgrade
|
| Operating Cash Flow Growth | -12.71% | -49.56% | 20.09% | 147.20% | -48.87% | 112.68% | Upgrade
|
| Capital Expenditures | -6.9 | -7.13 | -7.84 | -6.19 | -4.35 | -6.49 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.02 | 0.02 | 0.07 | 0.02 | 0.07 | 0.03 | Upgrade
|
| Cash Acquisitions | - | -0.6 | -0.29 | 1.83 | -9.31 | -7.35 | Upgrade
|
| Sale (Purchase) of Intangibles | -42.72 | -42.71 | -43.16 | -36.92 | -38.44 | -50.45 | Upgrade
|
| Investment in Securities | 0.39 | -0.08 | -0.08 | -0.71 | -4.19 | -2.91 | Upgrade
|
| Other Investing Activities | 3.68 | 2.19 | 0.15 | 0.26 | 0.23 | 0.39 | Upgrade
|
| Investing Cash Flow | -45.53 | -48.31 | -51.15 | -41.72 | -56 | -66.76 | Upgrade
|
| Long-Term Debt Issued | - | 40 | - | 25.04 | 1.05 | - | Upgrade
|
| Long-Term Debt Repaid | - | -65.64 | -6.51 | -90.04 | -5.73 | -5 | Upgrade
|
| Net Debt Issued (Repaid) | -45.47 | -25.64 | -6.51 | -65 | -4.68 | -5 | Upgrade
|
| Issuance of Common Stock | 19.85 | 21.13 | 6.31 | - | - | 0.88 | Upgrade
|
| Common Dividends Paid | - | - | - | - | - | -11.08 | Upgrade
|
| Other Financing Activities | -9.28 | -15.66 | -10.47 | -2.81 | -6.6 | -2.46 | Upgrade
|
| Financing Cash Flow | -34.9 | -20.18 | -10.67 | -67.81 | -11.28 | -17.66 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.22 | -1.54 | -0.99 | 1.21 | -5.8 | -1.75 | Upgrade
|
| Net Cash Flow | 4.34 | -10.86 | 54.5 | -10.63 | -33.55 | -8.87 | Upgrade
|
| Free Cash Flow | 78.11 | 52.04 | 109.48 | 91.5 | 35.17 | 70.8 | Upgrade
|
| Free Cash Flow Growth | -14.05% | -52.46% | 19.65% | 160.14% | -50.32% | 143.95% | Upgrade
|
| Free Cash Flow Margin | 21.35% | 9.02% | 17.55% | 22.10% | 10.55% | 18.39% | Upgrade
|
| Free Cash Flow Per Share | 10.74 | 7.30 | 15.42 | 13.19 | 5.07 | 10.23 | Upgrade
|
| Cash Interest Paid | 1.97 | 1.51 | 1.43 | 2.79 | 2.68 | 2.54 | Upgrade
|
| Cash Income Tax Paid | 2.7 | 5.96 | -4.93 | -0.71 | 6.89 | 9.4 | Upgrade
|
| Levered Free Cash Flow | 43.27 | -2.32 | 23.74 | 46.61 | -8.5 | 6.42 | Upgrade
|
| Unlevered Free Cash Flow | 43.27 | -1.24 | 25.02 | 48.32 | -6.23 | 8.27 | Upgrade
|
| Change in Net Working Capital | -67.29 | 40.23 | 46.38 | -32.53 | 0.15 | -7.72 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.